Bayesian modelling of an epidemic of severe acute respiratory syndrome

This paper analyses data arising from a SARS epidemic in Shanxi province of China involving a total of 354 people infected with SARS-CoV between late February and late May 2003. Using Bayesian inference, we have estimated critical epidemiological determinants. The estimated mean incubation period was 5.3 days (95% CI 4.2–6.8 days), mean time to hospitalisation was 3.5 days (95% CI 2.8–3.6 days), mean time from symptom onset to recovery was 26 days (95% CI 25–27 days) and mean time from symptom onset to death was 21 days (95% CI 16–26 days). The reproduction ratio was estimated to be 4.8 (95% CI 2.2–8.8) in the early part of the epidemic (February and March 2003) reducing to 0.75 (95% CI 0.65–0.85) in the later part of the epidemic (April and May 2003). The infectivity of symptomatic SARS cases in hospital and in the community was estimated. Community SARS cases caused transmission to others at an estimated rate of 0.4 per infective per day during the early part of the epidemic, reducing to 0.2 in the later part of the epidemic. For hospitalised patients, the daily infectivity was approximately 0.15 early in the epidemic, but fell to 0.0006 in the later part of the epidemic. Despite the lower daily infectivity level for hospitalised patients, the long duration of the hospitalisation led to a greater number of transmissions within hospitals compared with the community in the early part of the epidemic, as estimated by this study. This study investigated the individual infectivity profile during the symptomatic period, with an estimated peak infectivity on the ninth symptomatic day.

[1]  A. Danchin,et al.  The Severe Acute Respiratory Syndrome , 2003 .

[2]  Y. Guan,et al.  The severe acute respiratory syndrome. , 2003, The New England journal of medicine.

[3]  K. Turksen,et al.  Isolation and characterization , 2006 .

[4]  O. Diekmann.  Mathematical Epidemiology of Infectious Diseases , 1996 .

[5]  C. Orellana.  Laboratory-acquired SARS raises worries on biosafety , 2004, The Lancet Infectious Diseases.

[6]  Christopher W. Wong,et al.  Laboratory-acquired severe acute respiratory syndrome. , 2004, The New England journal of medicine.

[7]  Joseph S. Bresee,et al.  Cluster of SARS among Medical Students Exposed to Single Patient, Hong Kong , 2004, Emerging infectious diseases.

[8]  R. Webster.  Wet markets—a continuing source of severe acute respiratory syndrome and influenza? , 2004, The Lancet.

[9]  W. Lim,et al.  Viral shedding patterns of coronavirus in patients with probable severe acute respiratory syndrome , 2004, The Lancet.

[10]  Sze-Bi Hsu,et al.  SARS Outbreak, Taiwan, 2003 , 2004, Emerging infectious diseases.

[11]  A. Roddam.  Mathematical Epidemiology of Infectious Diseases: Model Building, Analysis and Interpretation O Diekmann and JAP Heesterbeek, 2000, Chichester: John Wiley pp. 303, £39.95. ISBN 0-471-49241-8 , 2001 .

[12]  C. Fraser,et al.  Transmission Dynamics of the Etiological Agent of SARS in Hong Kong: Impact of Public Health Interventions , 2003, Science.

[13]  G. Chowell,et al.  SARS outbreaks in Ontario, Hong Kong and Singapore: the role of diagnosis and isolation as a control mechanism , 2003, Journal of Theoretical Biology.

[14]  J. A. Comer,et al.  A novel coronavirus associated with severe acute respiratory syndrome. , 2003, The New England journal of medicine.

[15]  Y. Guan,et al.  The aetiology, origins, and diagnosis of severe acute respiratory syndrome , 2004, The Lancet Infectious Diseases.

[16]  Y. Guan,et al.  Coronavirus as a possible cause of severe acute respiratory syndrome , 2003, The Lancet.

[17]  D. Normile.  Mounting Lab Accidents Raise SARS Fears , 2004, Science.

[18]  M. E. Alexander,et al.  Modelling strategies for controlling SARS outbreaks , 2004, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[19]  J. Wallinga,et al.  Different Epidemic Curves for Severe Acute Respiratory Syndrome Reveal Similar Impacts of Control Measures , 2004, American journal of epidemiology.

[20]  Peter Cameron,et al.  A major outbreak of severe acute respiratory syndrome in Hong Kong. , 2003, The New England journal of medicine.

[21]  L. Poon,et al.  Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia : a prospective study , 2003 .

[22]  B. C. Choi,et al.  A simple approximate mathematical model to predict the number of severe acute respiratory syndrome cases and deaths , 2003, Journal of epidemiology and community health.

[23]  Christian Drosten,et al.  Identification of a novel coronavirus in patients with severe acute respiratory syndrome. , 2003, The New England journal of medicine.

[24]  W. O. Kermack,et al.  A contribution to the mathematical theory of epidemics , 1927 .

[25]  P. Kaye.  Infectious diseases of humans: Dynamics and control , 1993 .

[26]  Xu Han-You,et al.  Acute Respiratory Syndrome (SARS) , 2004 .

[27]  C. Fraser,et al.  Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong , 2003, The Lancet.

[28]  Y. Leo,et al.  Factors associated with transmission of severe acute respiratory syndrome among health-care workers in Singapore , 2004, Epidemiology and Infection.

[29]  A L Lloyd,et al.  Destabilization of epidemic models with the inclusion of realistic distributions of infectious periods , 2001, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[30]  M. Meltzer,et al.  Multiple Contact Dates and SARS Incubation Periods , 2004, Emerging infectious diseases.

[31]  W. O. Kermack,et al.  Contributions to the mathematical theory of epidemics—I , 1991, Bulletin of mathematical biology.

[32]  Christl A. Donnelly,et al.  SARS-CoV Antibody Prevalence in All Hong Kong Patient Contacts , 2004, Emerging infectious diseases.

[33]  H. Akaike.  A new look at the statistical model identification , 1974 .

[34]  Shigui Ruan,et al.  Simulating the SARS outbreak in Beijing with limited data , 2003, Journal of Theoretical Biology.

[35]  Arthur S Slutsky,et al.  Identification of severe acute respiratory syndrome in Canada. , 2003, The New England journal of medicine.

[36]  J. Robins,et al.  Transmission Dynamics and Control of Severe Acute Respiratory Syndrome , 2003, Science.

[37]  X. L. Liu,et al.  Isolation and Characterization of Viruses Related to the SARS Coronavirus from Animals in Southern China , 2003, Science.

[38]  Elizabeth Rea,et al.  Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. , 2003, JAMA.

[39]  Kow-Tong Chen,et al.  Transmission of the severe acute respiratory syndrome on aircraft. , 2003, The New England journal of medicine.

[40]  C. Fraser,et al.  Epidemiological and genetic analysis of severe acute respiratory syndrome , 2004, The Lancet Infectious Diseases.

[41]  Gowri Gopalakrishna,et al.  SARS Transmission and Hospital Containment , 2004, Emerging infectious diseases.

[42]  I. Yu,et al.  Predicting Super Spreading Events during the 2003 Severe Acute Respiratory Syndrome Epidemics in Hong Kong and Singapore , 2004, American journal of epidemiology.